Japanese and Taiwanese shares recovered on Monday after last week’s AI-driven sell-off, but South Korea’s reversal highlighted fragile investor confidence.
CINCINNATI, Nov. 03, 2026 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers,
SAN JOSE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal
Record quarterly revenue of $584.9 million, up 49% QoQ and up 154% year-over-year Scorpio™ fabric switches became the company’s largest product family, led by volume production of the Scorpio X-Series 320-lane fabric
$37.8 million net revenue for Q3 2026, driven by $34.0 million in revenue from MIPLYFFA 45% increase in total net revenue over Q3 2025 Operational execution fueled strong cash position of $270.9
ALISO VIEJO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights Total revenue of
PONTE VEDRA, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of
MIAMI, Nov. 03, 2026 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for November 2026 of $0.08 per share, comprised of a $0.04 per share base
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative and broadly accessible pipeline of induced pluripotent stem cell (iPSC)-derived
Company commits to independent board oversight; Preserves all shareholders’ positions by rescinding proposed reverse split FAIRFAX, Va., Nov. 03, 2026 (GLOBE NEWSWIRE) — Visium Technologies, Inc. (OTC: VISM) (“Visium” or the “Company”),
Executing Against Transformational ROI Strategy for Long-Term Value Creation Reaffirming Full Year 2026 Outlook RESTON, Va., Nov. 03, 2026 (GLOBE NEWSWIRE) — comScore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting
Follow